Spider-Man: Brand New Day is set to return to theaters on December 4, 2026, in an extended cut featuring new footage of Rosario Dawson as Night Nurse, according to Deadline. The trade reports that the version will be called Spider-Man: [Brand New] Brand New Day, with tickets going on sale November 19.
The reported addition gives viewers a reason to revisit a film that opened only a few months ago. Night Nurse is a familiar figure from Marvel television, and Dawson had previously discussed filming a scene for Brand New Day that did not make the original cut.
The theatrical return would also put the movie back on screens during awards season. Sony has told Deadline it is launching an awards campaign for the film, which was directed by Destin Daniel Cretton.
What the extended cut means for Night Nurse
The reported version will add scenes to the film, including material featuring Dawson’s Night Nurse. The report does not establish whether the scene Dawson previously said was cut is among the new footage, or describe what happens in her added material.
Night Nurse has appeared in Marvel TV’s Daredevil, Iron Fist, Luke Cage and The Defenders. That history gives the reported appearance a connection to a character audiences have seen across multiple series, rather than one introduced solely for the new theatrical release.
For those looking to book, the reported title is the detail to watch for: Spider-Man: [Brand New] Brand New Day distinguishes the extended version from the film’s original theatrical release. The November 19 ticket date would fall 15 days before its planned return to cinemas.
The original film opened on July 31, so the December date would bring it back a little over four months later. The new footage is the reason the reported release is being presented as a different cut, rather than simply another screening of the version that opened in summer.
A second theatrical run during awards season
The reported re-release follows a major opening for the Marvel Studios and Pascal Pictures production. The film took $360 million in North America on its first weekend, including $72 million in previews, and opened to $932 million globally, according to Deadline.
The preview figure represents one-fifth of the reported North American opening. Deadline described both the regional opening and the preview result as records, and ranked the global debut as the second-biggest ever. Those figures concern the film’s initial release, not ticket sales for the planned extended cut.
Sony’s awards campaign is a separate development from the reported theatrical return. The timing nevertheless puts the new cut in cinemas while the studio is seeking awards attention for the film, including a campaign aimed at the best-picture Oscar.
Sony Pictures Motion Picture Group chairman and CEO Tom Rothman discussed the film’s prospects in an interview with Deadline. “The Academy is meant to recognize greatness,” Rothman said, making the case for the film to be considered.
For audiences, the next date in the reported schedule is November 19, when sales for the extended cut are expected to begin. If the release proceeds as reported, viewers will be able to see the new version in theaters from December 4.


